180 related articles for article (PubMed ID: 28124082)
1. Novel compound heterozygous mutations in ZAP70 in a Chinese patient with leaky severe combined immunodeficiency disorder.
Liu Q; Wang YP; Liu Q; Zhao Q; Chen XM; Xue XH; Zhou LN; Ding Y; Tang XM; Zhao XD; Zhang ZY
Immunogenetics; 2017 Apr; 69(4):199-209. PubMed ID: 28124082
[TBL] [Abstract][Full Text] [Related]
2. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency.
Turul T; Tezcan I; Artac H; de Bruin-Versteeg S; Barendregt BH; Reisli I; Sanal O; van Dongen JJ; van der Burg M
Eur J Pediatr; 2009 Jan; 168(1):87-93. PubMed ID: 18509675
[TBL] [Abstract][Full Text] [Related]
3. A novel zeta-associated protein 70 homozygous mutation causing combined immunodeficiency presenting as neonatal autoimmune hemolytic anemia.
Ling E; Broides A; Ling G; Shubinsky G; Hadad N; Nahum A; Simon AJ; Lev A; Somech R
Immunol Res; 2021 Feb; 69(1):100-106. PubMed ID: 33484432
[TBL] [Abstract][Full Text] [Related]
4. Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity.
Picard C; Dogniaux S; Chemin K; Maciorowski Z; Lim A; Mazerolles F; Rieux-Laucat F; Stolzenberg MC; Debre M; Magny JP; Le Deist F; Fischer A; Hivroz C
Eur J Immunol; 2009 Jul; 39(7):1966-76. PubMed ID: 19548248
[TBL] [Abstract][Full Text] [Related]
5. SYK expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling.
Hauck F; Blumenthal B; Fuchs S; Lenoir C; Martin E; Speckmann C; Vraetz T; Mannhardt-Laakmann W; Lambert N; Gil M; Borte S; Audrain M; Schwarz K; Lim A; Schamel WW; Fischer A; Ehl S; Rensing-Ehl A; Picard C; Latour S
Clin Immunol; 2015 Dec; 161(2):103-9. PubMed ID: 26187144
[TBL] [Abstract][Full Text] [Related]
6. A novel Zap70 mutation with reduced protein stability demonstrates the rate-limiting threshold for Zap70 in T-cell receptor signalling.
Cauwe B; Tian L; Franckaert D; Pierson W; Staats KA; Schlenner SM; Liston A
Immunology; 2014 Mar; 141(3):377-87. PubMed ID: 24164480
[TBL] [Abstract][Full Text] [Related]
7. Novel Compound Heterozygous Mutations in ZAP70 Leading to a SCID Phenotype with Normal Downstream In vitro Signaling.
Kaman K; Abrams M; Dobbs K; Notarangelo LD; Delmonte OM; Palterer B; Pai SY; Johnston A
J Clin Immunol; 2021 Feb; 41(2):470-472. PubMed ID: 33184721
[No Abstract] [Full Text] [Related]
8. Clinical, Immunological, and Genetic Features in 49 Patients With ZAP-70 Deficiency: A Systematic Review.
Sharifinejad N; Jamee M; Zaki-Dizaji M; Lo B; Shaghaghi M; Mohammadi H; Jadidi-Niaragh F; Shaghaghi S; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Front Immunol; 2020; 11():831. PubMed ID: 32431715
[No Abstract] [Full Text] [Related]
9. Characterization of ΞΆ-associated protein, 70 kd (ZAP70)-deficient human lymphocytes.
Roifman CM; Dadi H; Somech R; Nahum A; Sharfe N
J Allergy Clin Immunol; 2010 Dec; 126(6):1226-33.e1. PubMed ID: 20864151
[TBL] [Abstract][Full Text] [Related]
10. Novel Compound Heterozygous ZAP70 R37G A507T Mutations in Infant with Severe Immunodeficiency.
Benavides N; White JC; Sanmillan ML; Thomas M; Le T; Caywood E; Giraudo CG
J Clin Immunol; 2023 Dec; 44(1):27. PubMed ID: 38129328
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder.
Karaca E; Karakoc-Aydiner E; Bayrak OF; Keles S; Sevli S; Barlan IB; Yuksel A; Chatila TA; Ozen M
Gene; 2013 Jan; 512(2):189-93. PubMed ID: 23124046
[TBL] [Abstract][Full Text] [Related]
12. Combined immunodeficiency caused by pathogenic variants in the
Mongellaz C; Vicente R; Noroski LM; Noraz N; Courgnaud V; Chinen J; Faria E; Zimmermann VS; Taylor N
Front Immunol; 2023; 14():1155883. PubMed ID: 37313400
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.
Cuvelier GD; Rubin TS; Wall DA; Schroeder ML
J Clin Immunol; 2016 Oct; 36(7):713-24. PubMed ID: 27438785
[TBL] [Abstract][Full Text] [Related]
14. Limitation of TREC-based newborn screening for ZAP70 Severe Combined Immunodeficiency.
Grazioli S; Bennett M; Hildebrand KJ; Vallance H; Turvey SE; Junker AK
Clin Immunol; 2014 Jul; 153(1):209-10. PubMed ID: 24797280
[No Abstract] [Full Text] [Related]
15. Lymphocyte disturbance and functional assessment of the [Asp521Asn] ZAP70 mutation.
Lin YF; Lee WI; Ho CH; Chen SH; Hsu MH; Wu RC; Lee WF; Jaing TH; Huang JL; Tsai SF
Clin Immunol; 2023 Feb; 247():109236. PubMed ID: 36669607
[TBL] [Abstract][Full Text] [Related]
16. ZAP70 deficiency promotes reverse cholesterol transport through MAPK/ERK pathway in Jurkat cell.
Liu J; Guo K; Hu L; Luo T; Ma Y; Zhang Y; Lai W; Guo Z
Mol Immunol; 2019 Mar; 107():21-28. PubMed ID: 30639475
[TBL] [Abstract][Full Text] [Related]
17. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70.
Chan AY; Punwani D; Kadlecek TA; Cowan MJ; Olson JL; Mathes EF; Sunderam U; Fu SM; Srinivasan R; Kuriyan J; Brenner SE; Weiss A; Puck JM
J Exp Med; 2016 Feb; 213(2):155-65. PubMed ID: 26783323
[TBL] [Abstract][Full Text] [Related]
18. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.
Yu X; Almeida JR; Darko S; van der Burg M; DeRavin SS; Malech H; Gennery A; Chinn I; Markert ML; Douek DC; Milner JD
J Allergy Clin Immunol; 2014 Apr; 133(4):1109-15. PubMed ID: 24406074
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Epstein-Barr Virus Infection in Hypomorphic ZAP70 Mutation.
Hoshino A; Takashima T; Yoshida K; Morimoto A; Kawahara Y; Yeh TW; Okano T; Yamashita M; Mitsuiki N; Imai K; Sakatani T; Nakazawa A; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Morio T; Kanegane H
J Infect Dis; 2018 Jul; 218(5):825-834. PubMed ID: 29684201
[TBL] [Abstract][Full Text] [Related]
20. Novel Mutation of ZAP-70-related Combined Immunodeficiency: First Case from the National Iranian Registry and Review of the Literature.
Shirkani A; Shahrooei M; Azizi G; Rokni-Zadeh H; Abolhassani H; Farrokhi S; Frans G; Bossuyt X; Aghamohammadi A
Immunol Invest; 2017 Jan; 46(1):70-79. PubMed ID: 27759478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
